Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors
Abstract Though programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors have revolutionized cancer treatment, predicting their therapeutic efficacy largely depends on biomarkers obtained through invasive procedures, which present challenges, particularly for continuous...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2026-01-01
|
| Reeks: | Biomarker Research |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s40364-026-00892-5 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|